News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC welcomes Medsafe approval of Herceptin

Media release

PHARMAC welcomes Medsafe approval of Herceptin

Medsafe’s decision to provisionally approve the wider use of the breast cancer drug Herceptin is welcomed and will enable PHARMAC to progress its assessment further, says PHARMAC spokeswoman Dr Dilky Rasiah.

Data on Herceptin has been reviewed by the expert clinical committee PTAC. Further data has been received and will be taken to PTAC’s cancer treatments sub-committee in April.

“Now that Medsafe has granted provisional approval we are in a good position to move forward,” Dr Rasiah says.

“We have already moved quickly to examine the preliminary data. The next step is to obtain advice from the cancer treatments sub-committee, and a final recommendation from PTAC.”

Dr Rasiah says in addition to the clinical data, an economic analysis of Herceptin and the total budgetary cost will also be important factors for PHARMAC and DHBs to consider. Because Herceptin is a drug administered in hospitals, it would be funded from DHB hospital budgets.

“At this stage we can’t guarantee that Herceptin will be funded. We have to determine if the clinical data and cost-effectiveness stacks up. If it does, we then have to reach an agreement with the supplier, Roche, that could make it affordable for DHBs. Finally, DHBs will have to decide if this is something they can afford.”

“In looking at Herceptin we have to consider what impact a decision to fund it might have on our ability to fund other drugs in the future. Spending $30 million on Herceptin would constrain our ability to fund other drugs we are currently considering, so we are keen to work with Roche to find a way to make it affordable.”

Dr Rasiah says PHARMAC will continue working with Roche and District Health Boards to progress the assessment of Herceptin as quickly as possible.


Herceptin timelines

Timeline to date

- December 2005: PHARMAC receives application from Roche to fund Herceptin for early breast cancer.

- 18 February 2006: The Pharmacology and Therapeutics Advisory Committee (PTAC) considers application for early breast cancer. PTAC recommends further information be sought from Roche and for Herceptin to be considered by the cancer treatments sub-committee, should Herceptin be approved by Medsafe.

- 23 March 2006: Medsafe grants provisional consent to Herceptin

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Electronica: Restoring The World’s First Recorded Computer Music

University of Canterbury Distinguished Professor Jack Copeland and UC alumni and composer Jason Long have restored the earliest known recording of computer-generated music, created more than 65 years ago using programming techniques devised by Alan Turing. More>>


Scoop Review Of Books: Almost Getting Away With Murder

The Black Widow by Lee-Anne Cartier: Lee-Anne Cartier is the sister of the Christchurch man found to have been murdered by his wife, Helen Milner, after an initial assumption by police that his death, in 2009, was suicide. More>>

Howard Davis: Triple Echo - The Malevich/Reinhardt/Hotere Nexus

Howard Davis: The current juxtaposition of works by Ralph Hotere and Ad Reinhardt at Te Papa perfectly exemplifies Jean Michel Massing's preoccupation with the transmigration of imagery in a remarkable triple echo effect... More>>

Scoop Review Of Books: Nō Tāu Manawa

Vaughan Rapatahana responds to Fale Aitu | Spirit House by Tusiata Avi: "fa’afetai Tusiata, fa’afetai, / you’ve swerved & served us a masterclass corpus / through graft / of tears & fears..." More>>

9 Golds - 21 Medals: NZ Team Celebrates As Rio 2016 Paralympic Games Close

The entire New Zealand Paralympic Team, led by kiwi sprinter and double gold medallist Liam Malone as flag bearer, are on the bus to the Maracanã Stadium in Rio de Janeiro for the Closing Ceremony of the Rio 2016 Paralympic Games. There, they will celebrate the fantastic successes of the past 10 days. More>>


New Zealand Improv Festival: The Festival Of Moments To Return To The Capital

The eighth incarnation of the New Zealand Improv Festival comes to BATS Theatre this 4-8 October , with a stellar line-up of spontaneous theatre and instant comedy performed and directed by top improvisors from around New Zealand and the world. More>>


Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news